Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe,

Slides:



Advertisements
Similar presentations
Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis  Dariush Haghmorad, Mohammad Bagher.
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β- Defensins via Induction of Regulatory T Cells  Anika Bruhs, Thomas.
CD4+CD25+ Immunoregulatory T Cells
Volume 33, Issue 3, Pages (September 2010)
Volume 137, Issue 3, Pages (September 2009)
Identification of CD3+CD4−CD8− T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD)  Fumi Miyagawa,
Thymic Selection by a Single MHC/Peptide Ligand
Volume 32, Issue 3, Pages (March 2010)
Antigen-Specific Peripheral Tolerance Induced by Topical Application of NF-κB Decoy Oligodeoxynucleotide  Iwao Isomura, Kunio Tsujimura, Akimichi Morita 
Volume 8, Issue 6, Pages (June 1998)
Volume 19, Issue 6, Pages (December 2003)
Durbaka V.R Prasad, Sabrina Richards, Xoi Muoi Mai, Chen Dong  Immunity 
Volume 30, Issue 4, Pages (April 2009)
Volume 137, Issue 3, Pages (September 2009)
Volume 18, Issue 5, Pages (May 2003)
Volume 32, Issue 5, Pages (May 2010)
Ananda W Goldrath, Michael J Bevan  Immunity 
Volume 140, Issue 7, Pages (June 2011)
Giandomenica Iezzi, Klaus Karjalainen, Antonio Lanzavecchia  Immunity 
Volume 21, Issue 5, Pages (November 2004)
Mechanism Underlying Counterregulation of Autoimmune Diabetes by IL-4
Designing and Maintaining the Mature TCR Repertoire
Volume 6, Issue 4, Pages (April 1997)
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 31, Issue 2, Pages (August 2009)
Volume 33, Issue 3, Pages (September 2010)
Volume 21, Issue 3, Pages (September 2004)
Volume 14, Issue 1, Pages (January 2001)
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
Volume 16, Issue 3, Pages (March 2002)
T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation  Ming O. Li, Yisong Y. Wan, Richard.
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells  Dan Blat, Ehud Zigmond, Zoya Alteber,
Volume 29, Issue 6, Pages (December 2008)
Volume 16, Issue 2, Pages (February 2002)
Volume 36, Issue 6, Pages (June 2012)
Volume 5, Issue 3, Pages (September 1996)
Volume 33, Issue 4, Pages (October 2010)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 32, Issue 5, Pages (May 2010)
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 119, Issue 1, Pages (July 2000)
Cyclooxygenase-2 Inhibition Promotes Enhancement of Antitumor Responses by Transcutaneous Vaccination with Cytosine-Phosphate-Guanosine- Oligodeoxynucleotides.
Volume 29, Issue 1, Pages (July 2008)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Eric A Butz, Michael J Bevan  Immunity 
Volume 29, Issue 5, Pages (November 2008)
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 35, Issue 2, Pages (August 2011)
Volume 31, Issue 4, Pages (October 2009)
Volume 19, Issue 11, Pages (June 2017)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 34, Issue 3, Pages (March 2011)
Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10  Ela Martin, Brendan.
Volume 30, Issue 4, Pages (April 2009)
Volume 28, Issue 5, Pages (May 2008)
Volume 14, Issue 3, Pages (March 2001)
Volume 7, Issue 3, Pages (September 1997)
Volume 32, Issue 1, Pages (January 2010)
Notch 1 Signaling Regulates Peripheral T Cell Activation
Toll-Dependent Control Mechanisms of CD4 T Cell Activation
Mechanism Underlying Counterregulation of Autoimmune Diabetes by IL-4
Ovalbumin-specific IgE modulates ovalbumin-specific T-cell response after repetitive oral antigen administration  Nemuko Omata, MD, Yusei Ohshima, MD,
Volume 39, Issue 5, Pages (November 2013)
Volume 23, Issue 4, Pages (October 2005)
Volume 32, Issue 5, Pages (May 2010)
Volume 4, Issue 5, Pages (May 1996)
Volume 25, Issue 3, Pages (September 2006)
Volume 45, Issue 5, Pages (November 2016)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe, J.Tori Evans, Christophe Viret, Charles A. Janeway  Immunity  Volume 19, Issue 3, Pages 317-328 (September 2003) DOI: 10.1016/S1074-7613(03)00239-5

Figure 1 ECi with Ac1-11 Induces Dominant Tolerance in MBP-TCR-Tg Mice (A) MBP-TCR-Tg mice were ECi with varying doses of Ac1-11: 1 mg, 100 μg, 10 μg, 1 μg, 0.1 μg, or PBS. (B) To determine whether protection is Ac1-11 specific, mice were ECi with Ac1-11 at 10 μg, with OVA at 10 μg and 100 μg concentrations, with MOG35-55 at 10 μg, with PLP139-151 at 10 μg, or with PBS for comparison. Note that the same group of mice treated with 10 μg of Ac1-11 per patch is shown in both (A) and (B). (C) MBP-TCR-Tg mice were ECi with 10 μg of Ac1-11 and given anti-IL4, anti-IL-10, anti-TGF-β monoclonal antibodies or their isotype-matched controls, or PBS prior to and during ECi with Ac1-11 as well as after EAE induction. (D) Irradiated naive B10.PL mice were adoptively transferred with 1 × 107 total splenocytes from Ac1-11 ECi or naive MBP-TCR-Tg mice (control group), or cotransferred with cells from both naive and Ac1-11 ECi mice. (E) Spleen and lymph node cells from Ac1-11 ECi mice are stained with anti-CD4 and the 3H12 clonotypic antibody (top left). Profiles for sorted CD4+/3H12+ cells (top right) and naive MBP-TCR-Tg Cα−/− splenocytes (bottom) are also shown. (F) 1 × 106 sorted Ac1-11-specific CD4 T cells from Ac1-11 ECi mice or naive MBP-TCR-Tg mice were adoptively transferred into MBP-TCR-Tg Cα−/− recipients. Immunity 2003 19, 317-328DOI: (10.1016/S1074-7613(03)00239-5)

Figure 2 Ts Cells Suppress Effector Cell Proliferation by Cell-to-Cell Contact and Are Functionally Altered (A) MBP-TCR-Tg Cα−/− mice were adoptively transferred with varying doses of sorted CD4+CD25+ T cells (0.25 × 106 [open square], 0.5 × 106 [open triangle], 1 × 106 [open circle]) or CD4+CD25− T cells (0.25 × 106 [closed square], 0.5 × 106 [closed triangle], 1 × 106 [closed circle]) from Ac1-11 ECi mice and monitored for EAE. (B) Sorted CD4 T cells from various Ac1-11 ECi mice (closed triangle, closed diamond, closed square, open circle), naive MBP-TCR-Tg mice (open triangle), or mice with end-stage EAE (closed circle) were stimulated in vitro with Ac1-11 to determine their proliferation status. (C) Sorted CD4 T cells from Ac1-11 ECi (open circle) or naive MBP-TCR-Tg mice (closed square) were cultured with APCs and varying concentrations of Ac1-11 alone; CD4 T cells from Ac1-11 ECi mice were also cultured with APCs, and fixed Ac1-11 (10 μg/ml), and varying concentrations of IL-2 (closed triangle). (D) Sorted CD4 T cells from Ac1-11 ECi mice, when cocultured with naive MBP-TCR-Tg T cells in the presence of peptide and APCs, could suppress naive MBP-TCR-Tg CD4 T cell proliferation in vitro in a dose-dependent manner. (E) Varying concentrations of anti-IL-4, anti-IL-10, anti-TGF-β mAbs, and their corresponding isotype-matched controls did not block the Ts cell-mediated suppression of naive CD4 T cell proliferation in the presence of fixed numbers of APCs, Ts cells, and antigen in vitro. (F) In a transwell assay, various numbers of Ts cells were cultured directly with fixed numbers of APCs, effector cells, and antigen (closed circle), or separated from effector cells by a membrane (closed diamond). No inhibition was observed when Ts cells were separated from effector cells, and inhibition was specific to Ts cells as CD4 T cells from nontransgenic littermates (open triangle) showed no inhibition of proliferation. Immunity 2003 19, 317-328DOI: (10.1016/S1074-7613(03)00239-5)

Figure 3 ECi with CNS Antigens (Ac1-11, PLP139-151) Suppress Spontaneous and R-R-EAE (A) Four- to six-week-old MBP-TCR-Tg Cα−/− mice when ECi with Ac1-11 show substantial protection from spontaneous EAE when compared to PBS controls. (B) Pooled spleen and lymph node cells collected 5.5 months after ECi from Ac1-11 ECi-sp mice (closed symbol) or from control mice (open symbol) were adoptively transferred into naive MBP-TCR-Tg Cα−/− recipients, and EAE was induced. (C) CD4 T cells from Ac1-11 ECi mice (closed symbol) or from naive MBP-TCR-Tg Cα−/− mice (open symbol) were transferred into naive MBP-TCR-Tg Cα−/− recipients that were monitored for spontaneous disease. (D) (SJL x PLJ)F1 mice were ECi with varying doses of PLP139-151 peptide. As controls, mice were ECi with OVA, PBS, or MOG135-155 peptide, another CNS antigen. (E) (B10.PL x SJL)F1 mice were ECi with Ac1-11 at 100 μg, 10 μg, or OVA as control. (F) Representative MHC class II/CD11c distribution for epidermal APCs prepared after epicutaneous immunization. (G) Epidermal APCs from mice ECi with Ac1-11 or Ac1-11-CFA were incubated with naive antigen-specific CD4 T cells. CD4 T cells were reisolated prior to stimulation with Ac1-11 and fresh APCs. (H) APCs from skin-draining lymph nodes of mice that were ECi with Ac1-11, Ac1-11-CFA, or PBS were cultured with naive antigen-specific CD4 T cells without exogenous antigen. (I) APCs from skin-draining lymph nodes of Ac1-11-CFA ECi mice were cultured with naive antigen-specific CD4 T cells and Ac1-11 plus anti-MHC class II (Y3JP) mAb or isotype control. Immunity 2003 19, 317-328DOI: (10.1016/S1074-7613(03)00239-5)

Figure 4 Ts Cell-Mediated Suppression of IFN-γ Secretion by Naive CD4 T Cells and Lack of CD4 T Cell Infiltration in the Brain Parenchyma of Disease-Resistant Mice (A) Sera from disease resistant (Ac1-11 ECi), diseased (EAE), and unmanipulated (naive) mice were tested for the presence of IFN-γ by ELISA prior to (week 0) and during ECi (weeks 1–2) as well as after EAE induction (weeks 3–6). (B) CD4 T cells from protected (Ac1-11 ECi) mice, normal MBP-TCR-Tg (naive) mice, or mice with active (score 1–3.5) EAE were stimulated in vitro with Ac1-11, and the supernatants were tested for IFN-γ production by ELISA. Three mice were analyzed in each group. (C) ELISA measurement of IFN-γ production in supernatants obtained from cultures in which Ts suppressed the proliferative response of naive MBP-TCR-Tg T cells to cognate stimulation. (D) No CD4 T cell infiltration is detectable in the brain parenchyma of protected mice by immunohistochemistry. Sections of perfusion-fixed brain tissue from Ac1-11 ECi mice protected from spontaneous EAE (a), induced EAE (b), naive mice (c), and mice with clinical signs of EAE (score of 1.5 [d] and 3 [e]). (E) Detailed summary of histological analysis. Immunity 2003 19, 317-328DOI: (10.1016/S1074-7613(03)00239-5)